TrialPloS one2022

Novel approaches to analysis of the North Star Ambulatory Assessment (NSAA) in Duchenne muscular dystrophy (DMD): Observations from a phase 2 trial.

Francesco Muntoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.